SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-022977
Filing Date
2024-06-06
Accepted
2024-06-06 17:28:32
Documents
14
Period of Report
2024-05-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43844
  Complete submission text file 0001493152-24-022977.txt   273219

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tenku-20240531.xsd EX-101.SCH 4090
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tenku-20240531_def.xml EX-101.DEF 27618
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tenku-20240531_lab.xml EX-101.LAB 38290
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tenku-20240531_pre.xml EX-101.PRE 26235
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7233
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41534 | Film No.: 241026522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)